Reversal of symptomatic tumoral narcolepsy, with normalization of CSF hypocretin level.
Dauvilliers
Y
Y
Neurology Department, Gui de Chauliac Hospital, National Reference Network for Orphan Diseases, Narcolepsy and Idiopathic Hypersomnia, Montpellier, France. ydauvilliers@yahoo.fr
Abril
B
B
Charif
M
M
Quittet
P
P
Bauchet
L
L
Carlander
B
B
Touchon
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001921:Brain / Q000473:pathology / Q000503:physiopathology*; D001932:Brain Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D004569:Electroencephalography; D006683:HLA-DQ Antigens / Q000235:genetics; D059866:HLA-DQ beta-Chains; D006801:Humans; D007031:Hypothalamus / Q000473:pathology / Q000503:physiopathology; D047908:Intracellular Signaling Peptides and Proteins / Q000134:cerebrospinal fluid / Q000172:deficiency*; D016393:Lymphoma, B-Cell / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009290:Narcolepsy / Q000134:cerebrospinal fluid / Q000209:etiology* / Q000503:physiopathology; D009479:Neuropeptides / Q000134:cerebrospinal fluid / Q000172:deficiency*; D000068797:Orexins; D016896:Treatment Outcome
D006683:HLA-DQ Antigens; D059866:HLA-DQ beta-Chains; C069051:HLA-DQB1 antigen; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins